TNF Pharmaceuticals Inc

Here is the public summary page for TNF Pharmaceuticals Inc. Please login to see the complete information for TNF Pharmaceuticals Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how TNF Pharmaceuticals Inc stacks up relative to its peers.

Darwin Score	-7
Ticker	TNFA
Latest Price	0.09 USD as of close on 17-Jul-2025
3 Month price range	0.10 to 0.22 USD
Market Capitalisation	1.51Mn USD
Country	United States of America
Region	North America
Economic Sector	Health Care
Business Sector	Pharmaceuticals, Biotechnology & Life Sciences
Industry	Pharmaceuticals
Sub-Industry	Pharmaceuticals
Description	TNF Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog of derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. The company has a strategic alliance with DADA2 Foundation for research into the rare inflammatory disease DADA2 (Deficiency of Adenosine Deaminase 2). TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in New York, New York. See More ...
Company URL	https://tnfpharma.com

See Darwins Full Analysis for TNF Pharmaceuticals Inc

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for TNF Pharmaceuticals Inc. Further information and full detail is available when you login.

TMA Part	Focus of Analysis	TMA Score
Price	Analysis of performance, trend, RSI, OBV and moving averages	+3
Sentiment	News and Candle Patterns.	0
Fundamentals	Analyst Ratings, Valuation and Dividend analysis.	0
Flow	Institutional, Fund and Insider buying and selling.	0
Models	Forecast models.	-10

Alerts

There are 14 live alerts for TNF Pharmaceuticals Inc. All the alerts are positive.

Volume is 12.4x 20 day average. (Positive)
Oversold - The 30 week RSI is +27.7. (Positive)
Oversold - The 5 month RSI is +7.1. (Positive)
Oversold - The 15 month RSI is +25.6. (Positive)
Divergence: Px Down & OBV Up last 65 days. This alert has occurred 236 times over the last last year. The average forward returns are -4.0% over 5 days, -8.5% over 10 days, -13.0% over 15 days and -17.2% over 20 days. (Positive)
Divergence: Px Down & 15d RSI Up last 20 days. This alert has occurred 77 times over the last last year. The average forward returns are -0.6% over 5 days, -4.1% over 10 days, -9.3% over 15 days and -14.3% over 20 days. (Positive)
Divergence: Px Down & OBV Up last 20 days. This alert has occurred 186 times over the last last year. The average forward returns are -3.1% over 5 days, -7.5% over 10 days, -11.3% over 15 days and -15.0% over 20 days. (Positive)
High Volume 2x 65dma. This alert has occurred 48 times over the last last year. The average forward returns are -13.0% over 5 days, -19.7% over 10 days, -24.8% over 15 days and -29.6% over 20 days. (Positive)
High Volume 2x 20dma. This alert has occurred 35 times over the last last year. The average forward returns are -13.6% over 5 days, -20.2% over 10 days, -25.7% over 15 days and -28.1% over 20 days. (Positive)
Divergence: Px Down & OBV Up last 10 days. This alert has occurred 162 times over the last last year. The average forward returns are -3.0% over 5 days, -8.1% over 10 days, -11.2% over 15 days and -16.1% over 20 days. (Positive)
Divergence: Px Down & 5d RSI Up last 10 days. This alert has occurred 62 times over the last last year. The average forward returns are 0.4% over 5 days, -3.3% over 10 days, -5.5% over 15 days and -13.3% over 20 days. (Positive)
Cross Over (Up): 5dma . This alert has occurred 33 times over the last last year. The average forward returns are -7.6% over 5 days, -12.5% over 10 days, -17.0% over 15 days and -21.0% over 20 days. (Positive)
High Volume 2x 130dma. This alert has occurred 64 times over the last last year. The average forward returns are -9.8% over 5 days, -17.1% over 10 days, -21.9% over 15 days and -26.7% over 20 days. (Positive)
Price crossing up through 5 day SMA. This alert has occurred 33 times over the last last year. The average forward returns are -7.6% over 5 days, -12.5% over 10 days, -17.0% over 15 days and -21.0% over 20 days. (Positive)

Peer Comparison

There is 1 peer of TNF Pharmaceuticals Inc.
Asset Name Industry Group Perf(20d)% Asset Score
Corcept Therapeutics Inc (CORT) Pharmaceuticals +1.7 +47